2m 2m 2m 2m 2m 2m 2m
TENAYA THERAP (TNYA)
NASDAQ
$0.65+$0.01 (+1.56%)
Price as of Sep 11, 2026 7:43 PM EDT- $143.5MMarket Cap
- -46.67%1-Year Change
- BiotechnologyIndustry
TENAYA THERAP (TNYA)
$0.65+$0.01 (+1.56%)
TNYA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.64 | ||
Change | -$0.009 (-1.36%) | ||
Open | $0.67 | ||
High | $0.67 | ||
Low | $0.64 | ||
Previous Close | $0.65 | ||
Volume | 1,375,182 | ||
30-Day Average Volume | 1,788,247 | ||
1-Week Change | -6.32% | ||
1-Month Change | -14.81% | ||
1-Year Change | -46.67% | ||
3-Year Change | -80.37% | ||
5-Year Change | -97.34% | ||
Fundamentals | |||
Shares Outstanding | 224.2M | ||
Total Assets | $93.5M | ||
Market Cap | $143.5M | ||
Enterprise Value | $65.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$43.4M | ||
Free Cash Flow | -$3.7M | ||
EBIT | -$43.4M | ||
EBITDA | -$41.7M | ||
Net Working Capital | $67.0M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 59 | ||
P/B | 2 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue